Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hemophilia B
hemophilia B
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Fierce Biotech
Wed, 08/3/16 - 09:39 am
Shire
Baxalta
hemophilia B
gene therapy
BAX 335
Spark Therapeutics
uniQure
Spark Therapeutics Surges After Gene Therapy Helps 3 Hemophilia Patients
Bloomberg
Thu, 05/19/16 - 03:31 pm
Spark Therapeutics
gene therapy
hemophilia B
SPK-9001
Pfizer
Positive hemophilia B gene-therapy results boost UniQure stock
BioPharma Dive
Sat, 01/9/16 - 10:37 am
uniQure
hemophilia B
UniQure's Gene Therapy Boosts Clotting in Two Hemophiliacs
Bloomberg
Thu, 01/7/16 - 08:57 am
uniQure
gene therapy
hemophilia B
AMT-060
3 Reasons That Biogen's Shares Could Rise
Investopedia
Wed, 06/17/15 - 10:05 am
Biogen
Alprolix
Eloctate
hemophilia A
hemophilia B
aducanumab
Alzheimer's disease
Pfizer dumps a hemophilia pact with Catalyst, threatening its Targacept merger
Fierce Biotech
Thu, 04/9/15 - 11:54 am
Pfizer
Catalyst Biosciences
M&A
Targacept
PF-05280602
hemophilia B
Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia
Fierce Biotech
Thu, 01/29/15 - 09:41 am
Biogen Idec
hemophilia B
hemophilia A
hemophilia
gene therapy
3 Reasons Biogen Idec Inc. Could Soar in 2015
Motley Fool
Fri, 12/12/14 - 08:50 am
Biogen Idec
Tecfidera
hemophilia B
MS
Alzheimer's disease
BIIB037
Pfizer (PFE) Enters Gene Therapy Arena; Offers To Settle Class Action Over Parkinson’s Drug
Bidness Etc.
Wed, 12/10/14 - 08:45 am
Pfizer
gene therapy
Spark Therapeutics
SPK-FIX
hemophilia B
Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform
Yahoo
Mon, 12/8/14 - 08:14 am
Pfizer
Rare Diseases
Spark Therapeutics
hemophilia B
Pfizer releases positive results from Phase III trial of BeneFIX to treat hemophilia B
Pharmaceutical Business Review
Sun, 07/20/14 - 09:31 am
Pfizer
BeneFix
hemophilia
hemophilia B
Pfizer says clotting drug's once-weekly dose reduces bleeding rate
Yahoo/Reuters
Wed, 07/16/14 - 10:20 am
Pfizer
BeneFix
hemophilia B
The price is right for patient-switching on Biogen's new hemophilia med Alprolix
Fierce Pharma
Tue, 04/22/14 - 09:30 am
Biogen Idec
hemophilia B
drug pricing
Alprolix
Biogen prices hemophilia drug on par with older therapies
Yahoo/Reuters
Fri, 04/18/14 - 04:38 pm
Biogen Idec
hemophilia B
Alprolix
Biogen hemophilia nod puts Baxter's to-be-spun-off biopharma unit on notice
Fierce Pharma
Mon, 03/31/14 - 04:42 pm
hemophilia B
Biogen Idec
Baxter International
Alprolix
Biogen Wins Approval for Long-Lasting Hemophilia B Treatment
Bloomberg
Sat, 03/29/14 - 09:10 am
Biogen Idec
Alprolix
hemophilia
hemophilia B
Biogen Idec says FDA will allow 3 more months to review its hemophilia B drug Alprolix
Yahoo/AP
Mon, 12/2/13 - 10:15 am
Biogen Idec
FDA
hemophilia B
Alprolix
U.S. FDA approves new Baxter drug for hemophilia B
Reuters
Fri, 06/28/13 - 12:22 pm
FDA
regulatory
Baxter
devices
hemophilia B
FDA approves new Baxter drug for hemophilia B
Reuters
Thu, 06/27/13 - 09:01 pm
hemophilia B
Baxter International
Rixubis
FDA
Positive Data on Novo Nordisk's N9-GP
Yahoo/Zacks
Wed, 05/22/13 - 09:41 am
Novo Nordisk
N9-GP
hemophilia B
Pages
« first
‹ previous
1
2
3
next ›
last »